Therapeutic considerations for postprandial dyslipidaemia.
Burnett
J R
JR
Department of Core Clinical Pathology and Biochemistry, Division of Laboratory Medicine, Royal Perth Hospital, Perth, WA, Australia.
Watts
G F
GF
D000818:Animals; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000178:diet therapy* / Q000188:drug therapy* / Q000523:psychology; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008019:Life Style; D008074:Lipoproteins / Q000378:metabolism; D019518:Postprandial Period / Q000187:drug effects
D000960:Hypolipidemic Agents; D008074:Lipoproteins